{"title":"O","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0027","DOIUrl":null,"url":null,"abstract":"This chapter presents information on neonatal drugs that begin with O, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Octreotide, Omeprazole, Ondansetron, Oral rehydration solution (ORS), Oseltamivir, Oxygen, and Oxytocin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"185 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"O\",\"authors\":\"Sean Ainsworth\",\"doi\":\"10.1093/med/9780198840787.003.0027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This chapter presents information on neonatal drugs that begin with O, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Octreotide, Omeprazole, Ondansetron, Oral rehydration solution (ORS), Oseltamivir, Oxygen, and Oxytocin\",\"PeriodicalId\":18908,\"journal\":{\"name\":\"Neonatal Formulary\",\"volume\":\"185 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neonatal Formulary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/med/9780198840787.003.0027\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neonatal Formulary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198840787.003.0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
This chapter presents information on neonatal drugs that begin with O, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Octreotide, Omeprazole, Ondansetron, Oral rehydration solution (ORS), Oseltamivir, Oxygen, and Oxytocin
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
